Lymphoma treatment approved.
D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy*; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D000069283:Rituximab; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab